DCF — MARY GREELEY MEDICAL CENTER
Enterprise Value: $-150.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-150.9M
Enterprise Value
$-52.2M
PV of Cash Flows
$-98.7M
PV of Terminal Value
$-159.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $227.0M | $-7.0M | -3.0% | $-16.6M | $-15.1M |
| Year 2 | $233.8M | $-4.8M | -2.0% | $-14.7M | $-12.2M |
| Year 3 | $240.8M | $-2.6M | -1.0% | $-12.8M | $-9.6M |
| Year 4 | $248.0M | $-1.4M | -1.0% | $-11.9M | $-8.1M |
| Year 5 | $255.4M | $-0.8M | -0.0% | $-11.6M | $-7.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-150.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$220.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03570285597216111
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5